Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Holders of 5% or more of BFRI
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Biofrontera Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Deutsche Balaton Aktiengesellschaft | 13D/A | 19.99%2.55M shares | +15.13 ppfrom 4.86% | Dec 20, 20243 filings | Sep 19, 2025 | SEC |
| Rosalind Advisors, Inc. | 13G/A | 9.90%16.8M shares | 0.00 ppfrom 9.90% | Feb 12, 20256 filings | Aug 12, 2026 | SEC |
| Hirschman Orin | 13G/A | 7.90%915.2K shares | −2.00 ppfrom 9.90% | Jan 29, 20252 filings | Jan 28, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
13 Schedule 13D and 13G filings on Biofrontera Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 20262:31 PM ET | Rosalind Advisors, Inc.and 3 others | 13G/A | 9.90%16.8M shares | 0.00 ppfrom 9.90% | Jun 30, 2026 | SEC |
| Feb 11, 202611:31 AM ET | Rosalind Advisors, Inc.and 3 others | 13G/A | 9.90%16.2M shares | 0.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Jan 28, 20262:10 PM ET | Hirschman Orinand 1 other | 13G/A | 7.90%915.2K shares | −2.00 ppfrom 9.90% | Dec 31, 2025 | SEC |
| Nov 12, 20252:52 PM ET | Rosalind Advisors, Inc.and 3 others | 13G/A | 9.90%16.8M shares | 0.00 ppfrom 9.90% | Oct 27, 2025 | SEC |
| Sep 19, 20253:04 PM ET | Deutsche Balaton Aktiengesellschaftand 7 others | 13D/A | 19.99%2.55M shares | +15.13 ppfrom 4.86% | Sep 16, 2025 | SEC |
| Aug 11, 20251:57 PM ET | Rosalind Advisors, Inc.and 3 others | 13G/A | 9.90%14.4M shares | 0.00 ppfrom 9.90% | Jun 30, 2025 | SEC |
| Jul 25, 20252:31 PM ET | Deutsche Balaton Aktiengesellschaftand 7 others | 13D/A | 4.86%458.9K shares | −1.06 ppfrom 5.92%Below 5% | Jun 30, 2025 | SEC |
| May 15, 20253:27 PM ET | Lytton Laurence W | 13G/A | 3.50%306.7K shares | –Below 5% | Mar 31, 2025 | SEC |
| May 13, 202511:07 AM ET | Rosalind Advisors, Inc.and 3 others | 13G/A | 9.90%9.89M shares | 0.00 ppfrom 9.90% | Mar 31, 2025 | SEC |
| Feb 12, 202511:29 AM ET | Rosalind Advisors, Inc.and 3 others | 13G/A | 9.90%9.96M shares | – | Dec 31, 2024 | SEC |
| Jan 29, 20257:58 PM ET | Hirschman Orinand 1 other | 13G/A | 9.90%884.6K shares | – | Dec 31, 2024 | SEC |
| Dec 20, 202412:40 PM ET | Deutsche Balaton Aktiengesellschaftand 5 others | 13D/A | 5.92%458.9K shares | – | Dec 20, 2024 | SEC |
| Feb 10, 2022 | Biofrontera AG | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Biofrontera Inc. shares.
No Form 144 notices for Biofrontera Inc. are on file.